Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 December 2022 | Story Lacea Loader | Photo Supplied
Prof Mogomme Masoga
Prof Mogomme Masoga, newly appointed Dean: Faculty of the Humanities.

The Council of the University of the Free State (UFS) approved the appointment of Prof Mogomme Masoga as Dean of the Faculty of the Humanities for a five-year term during its quarterly meeting on 25 November 2022. 

He is currently the Dean of the Faculty of Humanities and Social Sciences at the University of Zululand. 

“Prof Masoga has extensive and an impressive national and international research standing, established networks and partnerships, and substantive management experience. He is a visionary leader and a renowned scholar and will be able to lead and manage the faculty at academic, research, engaged scholarship, and community-service level,” says Prof Francis Petersen, UFS Rector and Vice-Chancellor. 

Prof Masoga holds a PhD in Philosophy from the University of the Free State. He began his academic career with a Bachelor of Arts from the University of KwaZulu-Natal, where he proceeded to complete two honours and a master’s degree. He received a second Master of Arts in Musicology from the University of South Africa.

Prof Masoga has an excellent record of research publication within the broad niche area of Oral History, Africanism, and Indigenous Knowledge System Studies. He has developed a well-grounded sense of autonomy and involvement, as he has been able to establish a number of research projects and has produced single and co-authored articles. He was able to synergise and sustain his research niche on Africanism and Indigenous Knowledge Studies, which has informed his research over the years. 

He has maintained a coherent research trajectory as a recognised NRF-rated scholar in Indigenous Knowledge System Studies. Prof Masoga’s participation in international collaborative projects has had a positive impact on his scholarly growth, as well as on other colleagues and departments in his faculty at the University of Zululand. 

“Prof Masoga will be able to sustain his existing networks and build new ones that will support research and postgraduate studies at the UFS. This will be particularly valuable in support of the university’s Vision 130, which expresses the institution’s strategic intent to position itself in the period leading up to 2034 when the university will be 130 years old. Vision 130 furthermore exemplifies our commitment to be acknowledged by our peers and society as a top-tier university in South Africa, ranked among the best in the world,” says Prof Petersen. 

Prof Masoga will assume duty on 1 March 2023.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept